DV Trading LLC Takes $6.29 Million Position in Tango Therapeutics, Inc. $TNGXMarket Beat·1 day ago, 03:24 AMTNGX-1.41%GS-A-5.00%
Under the radar: How US niche equities navigate AI, defense, and global M&AGlobal Report·Jul 30 at 04:13 AMASPC-1.67%LHAI+5.65%
Mizuho Securities Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)Tip Ranks·Jul 19 at 07:15 AMTNGX-1.41%
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga_article·Jul 15 at 05:59 AMTNGX-1.41%FISN-2.18%
The Great Uncoupling: Defense Tech Thrives While Consumer Stocks ScrambleGlobal Report·Jul 14 at 06:47 AMLITB+6.99%ZTO+0.67%
Tango Therapeutics President, R&D Crystal Adam disposes of common shares worth $798,704PUBT·Jul 2 at 06:24 PMTNGX-1.41%
Tango Therapeutics director Robert Azelby files initial beneficial ownership statementPUBT·Jun 23 at 05:04 PMTNGX-1.41%
As AbbVie eyes Apogee, these biotech stocks earn the highest quant ratingsMSN·Jun 22 at 08:55 AMNTLA-3.70%LEGN-2.62%
Tango Therapeutics Prices $566.5 Million Equity Offering at $30 Per Share; 30-Day Option GrantedTradingView·Jun 10 at 04:23 PMTNGX-1.41%JPM+0.27%
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering | TNGX Stock NewsStockTitan·Jun 9 at 01:49 PMTNGX-1.41%
